[Multidrug resistant bacteria in the intensive care unit : Reasonable measures for prevention]

Area of Science:

• Infectious Diseases
• Critical Care Medicine
• Microbiology

Background:

• Multidrug-resistant (MDR) bacteria, including methicillin-resistant staphylococcus aureus (MRSA), vancomycin-resistant enterococci, and MDR gram-negative bacteria, represent a significant and increasing threat to patients in intensive care units (ICUs).
• While MRSA colonization rates in German ICUs have stabilized with improved therapies, infections caused by other MDR pathogens are rising, presenting limited or no effective treatment options.
• Existing guidelines for MDR bacteria transmission prevention often lack robust evidence due to a scarcity of randomized controlled trials.

Purpose of the Study:

• To highlight the escalating threat of multidrug-resistant bacteria in intensive care settings.
• To emphasize the critical role of infection control measures in preventing the transmission of these resistant pathogens.
• To discuss the evidence supporting various strategies for combating MDR bacteria in ICUs.

Main Methods:

• Review of current trends in colonization and infection rates of MDR bacteria in intensive care patients.
• Analysis of existing recommendations and guidelines for the prevention of MDR bacteria transmission.
• Evaluation of the evidence base for infection control strategies, including hand hygiene, screening, barrier precautions, and decolonization.

Main Results:

• Colonization with MRSA in German ICUs has remained constant, but infections with MDR gram-negative bacteria and vancomycin-resistant enterococci are increasing.
• Effective therapeutic options for infections caused by these emerging MDR bacteria are scarce.
• Hand disinfection is identified as the single most important measure for preventing transmission of both susceptible and MDR bacteria.
• Screening and barrier precautions require pathogen- and condition-specific adaptation.
• Universal decolonization with antiseptics has demonstrated effectiveness, particularly in intensive care patients.

Conclusions:

• The increasing prevalence of difficult-to-treat MDR bacteria in ICUs necessitates stringent infection control measures.
• Hand hygiene remains the cornerstone of preventing pathogen transmission in critical care settings.
• A combination of tailored screening, barrier precautions, and potentially universal decolonization strategies is essential for managing MDR bacteria in ICUs.